Drawing for ALEXANDRIA

USPTO serial 87646697

ALEXANDRIA

Reviewed by CopyMark Law Group

Reg. 5700446Status 710
Filing date
Status date
Registration date
Mar 19, 2019
Examiner
CROWLEY, PAUL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALEXANDRIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joel D. Leviton

JOEL D. LEVITON STINSON LEONARD STREET LLP50 S 6TH ST STE 2600MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Antibody reagents for scientific purposes; nucleic acids for scientific purposes; clinical diagnostic reagents and clinical diagnostic reagent kits comprised primarily of monoclonal antibodies and monoclonal antibody fragments, buffers and reagents to detect the presence of antibody target antigens in human or animal tissues, or to detect the presence of therapeutic proteins or replacement enzymes in human or animal tissues for scientific laboratory use; chemical preparations for use in DNA analysis other than for medical or veterinary purposes; proteins for use in discovery, optimization and preclinical development of therapeutic and diagnostic antibodies using recombinant DNA technology other than for medical use; enzymes for use in the continuous homogenous isothermal amplifications of specific DNA templates other than for medical use; proteins for detecting antibodies other than for medical use; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic researchSECTION 8 - CANCELLED—
005Diagnostic and therapeutic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disorders; biochemical and biological substances for medical diagnostics and analysis, namely, diagnostic agents and reagents; pharmaceutical preparations and substances for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disorders; chemical preparations in the nature of reagents for use in DNA medical diagnostic analysis; nucleic acid sequences for medical use; synthetic peptides for pharmaceutical purposes for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disordersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025C8..CANCELLED SEC. 8 (6-YR)—
Mar 19, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 19, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 4, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 4, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 4, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2018ALIEASSIGNED TO LIE—
May 14, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2018DOCKASSIGNED TO EXAMINER—
Oct 25, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance